Literature DB >> 1022520

Substance P radioimmunoassay using Nalpha-tyrosyl-substance P and demonstration of the presence of substance P-like immunoreactivities in human blood and porcine tissue extracts.

C Yanaihara, H Sato, M Hirohashi, M Sakagami, K Yamamoto.   

Abstract

Sensitive and specific radioimmunoassay for substance P was developed using synthetic substance P and 125I-Nalpha-tyrosyl-substance P. Substance P-human alpha-globulin conjugate was used for production of anti-substance P antisera in rabbits. Synthetic substance P was used as a standard and the dextran-coated charcoal method was employed to separate the free peptide from that bound to antibodies. No cross-reactions by physalaemin and eledoisin observed in this system proved its high specificity to substance P. Nalpha-Tyrosyl-substance P and [Tyr1]-substance P showed the displacement curves indistinguishable from that of the standard substance P. Neither substance P5-11 nor substance P6-11 competed with the tracer at the concentration used. The minimum measurable dose of substance P by the assay system was 2.5-5 pg/incubate. Utilizing the system, human plasma samples from 42 healthy volunteers of both sexes were shown to contain immunoreactive substance P in amounts that averaged 298 pg/ml in male and 251 pg/ml in female. Substance P-like immunoreactivity was also demonstrated in hot-water extracts of porcine duodenum, jejunum, ileum, cecum, middle colon, rectum, pancreas, stomach and pituitary. The highest concentration (379 ng/g wet weight of organ) was found in the pituitary, and the ileum (7.9 ng/g wet weight of organ) and jejunum (1.9 ng/g wet weight of organ) were rich in the contents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1022520     DOI: 10.1507/endocrj1954.23.457

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  9 in total

1.  Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells.

Authors:  R T Jensen; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Elimination of substance P from the circulation of the rat and its inhibition by bacitracin.

Authors:  F Lembeck; P Holzer; M Schweditsch; R Gamse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

3.  Difference in behaviour between synthetic and endogenous substance P in human plasma.

Authors:  D E Cannon; P Skrabanek; D Powell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

4.  The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord.

Authors:  H Akagi; S Konishi; M Otsuka; M Yanagisawa
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

5.  Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting.

Authors:  Gerald M Higa; Miklos L Auber; Gerry Hobbs
Journal:  Support Care Cancer       Date:  2012-02-14       Impact factor: 3.603

6.  The intestine as source of immunoreactive substance P in plasma of the cat.

Authors:  R Gamse; E Mroz; S Leeman; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

7.  Chronopharmacology of enalapril in hypertensive patients.

Authors:  K Sunaga; A Fujimura; T Shiga; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Peptidergic innervation irregularities in Hirschsprung's disease. Immunohistochemistry--radioimmunoassay.

Authors:  T Taguchi; K Tanaka; K Ikeda; S Matsubayashi; N Yanaihara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

9.  Genome-wide association and identification of candidate genes for age at puberty in swine.

Authors:  Dan J Nonneman; James F Schneider; Clay A Lents; Ralph T Wiedmann; Jeffrey L Vallet; Gary A Rohrer
Journal:  BMC Genet       Date:  2016-02-29       Impact factor: 2.797

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.